Showing posts with label canadian trade policy. Show all posts
Showing posts with label canadian trade policy. Show all posts

Thursday, January 22, 2015

Another Compelling Video From Operation Maple

Operation Maple (Take Canada Back) is continuing its fine job of reminding us of the terrible way we are governed, offering us frequent and compelling evidence that demonstrates how the neo-liberal agenda, pursued with such diabolical glee by the Harper regime, is continuing to undermine our country. I suspect its resources, and others (the Salamander, for example, has some interesting ideas in this regard which I shall soon write about) will become increasingly important as we move ever closer to the next federal election. Please visit their site and disseminate their material as you see fit.

The following video explores the history of the free trade agreement and its costly consequences, consequences that continue to this day and promise to grow even more grave under the Canada-China Promotion and Protection Agreement (FIPA) and the Canada-Eu (CETA) deal.

Our sovereignty as a nation continues to erode thanks to these agreements, brokered with such secrecy, with the only true beneficiaries the corporate elites and the multinationals.

Thursday, October 31, 2013

What U.S. Steel Shutdown Reveals About Harper



While all of us continue to be riveted by the ever-deepening pit into which the duplicitous Prime Minister is digging himself over the Duffy scandal, other events are equally revelatory of Stephen Harper's dark psyche. One of them is the announcement by U.S. Steel that it is permanently shuttering its steel-making capacity in Hamilton.

Briefly, in 2007 the Harper government permitted the takeover of the troubled Stelco by U.S. Steel on the promise of certain undertakings, including employment guarantees, which I talked about in previous posts.
Those guarantees were never honoured, and despite the fact that the government took the company to court and won, it essentially gave a free pass to U.S. Steel, which then made new and unfulfilled promises to keep the plant going until 2015 and make capital investments of $50 million by the end of that time.

The charade of co-operation is now at an end, and as Thomas Walkom writes in today's Star,


From the federal government came a deafening silence.

A spokesperson for James Moore, the current industry minister, said only that the government doesn’t involve itself in the day-to-day business decisions of private companies.

And with that kiss-off, a steel-making operation that has defined manufacturing in Canada for 103 years came to an end.


Why should this be of broader concern to Canadians? In my view, it exemplifies the total disregard that the Harper regime has for the social and economic costs involved in industry betrayal. By dismissing such events as merely the result of implacable market forces, we perhaps have a window into what the so-far still secrecy-bound details of CETA have in store for even more employees and Canadian citizens in the near-future.

Sunday, November 18, 2012

A New Warning About CETA

While much has already been written about the economic threats to Canada inherent in the Canada-European Comprehensive Economic and Trade Agreement currently being negotiated in secret by the Harper regime, a new development in those negotiations has come to light that will cost all of us dearly.

In a piece entitled Harper government caves in to Big Pharma, Michael McBane reports the following:

Ottawa is prepared to give the Europeans, and the pharmaceutical industry, at least part of what they asked for on drug patents – a move that could cost Canadians up to $1 billion a year.

As McBane points out, thanks to a deal brokered by Brian Mulroney in the 1980's, Canada already pays 15 to 20 per cent more than the international average for new brand name drugs; at the time, the justification was the promise by the pharmaceuticals to invest 10 per cent of R&D (Research and Development)-to-sales in Canada, a figure that has never been realized. In fact, it currently stands at only 5.6 per cent of R&D-to-sales.

Yet despite pharma's betrayal of its undertaking, Canada is once more preparing to give away more of the shop through CETA; reports indicate

Canada will extend monopoly drug patents from 20 to 21 years. This patent extension will come without any conditions. In other words, we get nothing in return for this major concession. No jobs, no research, no innovation, no benefits whatsoever – only higher drug bills.

Prime Minister Harper is found of promoting the message that Canada is open for business. What he doesn't tell us is that it is the business of plundering and pillaging, hardly the basis for a domestic economic revival.